Christopher B Ehrlich is Director of PHOENIX BIOTECH ACQUISITION CORP.. Currently has a direct ownership of 478,825 shares of PBAXU, which is worth approximately $0. The most recent transaction as insider was on Feb 14, 2024, when has been sold 478,825 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 479K
0% 3M change
n/a 12M change
Total Value Held $0

Christopher B Ehrlich Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2024
BUY
Other acquisition or disposition
-
478,825 Added 50.0%
478,825 Common Stock

Also insider at

EFTR
eFFECTOR Therapeutics, Inc. Healthcare
CBE

Christopher B Ehrlich

Director
Solana Beach, CA

Track Institutional and Insider Activities on PBAXU

Follow PHOENIX BIOTECH ACQUISITION CORP. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PBAXU shares.

Notify only if

Insider Trading

Get notified when an Phoenix Biotech Acquisition Corp. insider buys or sells PBAXU shares.

Notify only if

News

Receive news related to PHOENIX BIOTECH ACQUISITION CORP.

Track Activities on PBAXU